SCHEMBL32665103

SCHEMBL32665103

O=C1C=CC(=O)N1C1CN(c2ccc(OS(=O)(=O)F)cc2)C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
HSP90AA1 P07900 2/20 0.33
CCR6 P51684 2/20 0.33
MEN1 O00255 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
MGLL Q99685 2/20 0.32
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CRBN Q96SW2 1/20 0.31
GAA P10253 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665356 0.89 DRD2 (0.34) ALDH1A1LMNAHSP90AA1CCR6MEN1
SCHEMBL32665143 0.86 L3MBTL3 (0.37) ALDH1A1LMNAHSP90AA1CCR6MEN1
SCHEMBL32665268 0.81 CYP2C9 (0.33) ALDH1A1LMNAHSP90AA1CCR6CACNA1B
SCHEMBL32665450 0.76 NOTUM (0.40) ALDH1A1MGLL
SCHEMBL32665174 0.76 NOTUM (0.40) ALDH1A1MGLL
SCHEMBL32665447 0.73 TDP1 (0.50) ALDH1A1LMNAHSP90AA1CCR6MEN1
SCHEMBL32665396 0.72 HRH1 (0.35) ALDH1A1LMNAHSP90AA1CCR6HPGD
SCHEMBL32665285 0.72 ALDH1A1 (0.36) ALDH1A1MGLL
SCHEMBL32665632 0.70 CHRM4 (0.36) ALDH1A1TDP1GAA
SCHEMBL17318128 0.68 CA2 (0.52) CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A ALDH1A1 3714/4885LMNA 2336/4885HSP90AA1 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.